Wulandari Bangun Laksana Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Wulandari Bangun Laksana Tbk trades at Rp52 (market cap 1.3T, 8.31M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Wulandari Bangun Laksana Tbk is far larger — about 2.2× UBC Medical Indonesia Tbk.'s market cap, and Wulandari Bangun Laksana Tbk is more actively traded (8.31M versus 817.3K). Which is the better fit depends on your goals.
| BSBK | LABS | |
|---|---|---|
Market Cap | 1.3T | 584.6B |
Volume | 8.31M | 817.3K |
Lot | 83.09K | 8.17K |
Turnover | 424.91M | 120.01M |
Average Price | 51.14 | 146.84 |
Value | 424.91M | 120.01M |
Indicative Equilibrium Price | 52 | 146 |
Indicative Equilibrium Volume | 3.32K | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Wulandari Bangun Laksana Tbk (the “Company”) was established under the name PT Dwipagrya Lestari in Jakarta based on Deed No. 21 dated September 7, 1994 by Linda Ibrahim, S.H., Notary in Jakarta. The Company commended its commercial operations on 2005.
Read more on BSBK →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →